Zoryve 0.3% topical cream Images
Generic Name: roflumilast
This medication has been identified as Zoryve 0.3% topical cream. It is supplied by Arcutis Biotherapeutics, Inc.
Zoryve is used in the treatment of Plaque Psoriasis and belongs to the drug class selective phosphodiesterase-4 inhibitors. Zoryve 0.3% topical cream is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Zoryve
- Generic Name
- roflumilast
- Strength
- 0.3% topical cream
- Availability
- Prescription only
- Drug Class
- Selective phosphodiesterase-4 inhibitors
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Arcutis Biotherapeutics, Inc.
- National Drug Code (NDC)
- 80610-0130
More about Zoryve (roflumilast topical)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (26)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: selective phosphodiesterase-4 inhibitors
- Breastfeeding
- En español
Patient resources
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
